Carla Ríos‐Luci

Resistance to the Antibody–Drug Conjugate T-DM1 Is Based in a Reduction in Lysosomal Proteolytic Activity

Carla Ríos‐Luci, Sara García‐Alonso, Elena Dı́az-Rodrı́guez et al. · Cancer Research · 2017 · 186 citations · Full text

Medicine, Oncology, Pharmacology +17

Antiproliferative activity of synthetic naphthoquinones related to lapachol. First synthesis of 5-hydroxylapachol

Evelyn L. Bonifazi, Carla Ríos‐Luci, Leticia G. León et al. · Bioorganic & Medicinal Chemistry · 2010 · 78 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12

Novel clioquinol and its analogous platinum complexes: importance, role of the halogen substitution and the hydroxyl group of the ligand

Cecilia Martín Santos, Silvia Cabrera, Carla Ríos‐Luci et al. · Dalton Transactions · 2013 · 77 citations

Pharmacy, Chemistry, Medicinal Chemistry +14

Model‐Based Nanoengineered Pharmacokinetics of Iron‐Doped Copper Oxide for Nanomedical Applications

Hendrik Naatz, Bella B. Manshian, Carla Ríos‐Luci et al. · Angewandte Chemie International Edition · 2019 · 58 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Antiproliferative activity of novel benzo[b][1,6]naphthyridines in human solid tumor cell lines

Simonas Rudys, Carla Ríos‐Luci, Eduardo Pérez-Roth et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 51 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +9